Video

Q&A With Paul Hudson of AstraZeneca US: 'Excitement' in Diabetes Treatment Progress

Author(s):

With so many people affected by diabetes finding the right treatment for the individual patients is becoming a key factor in care.

With so many people affected by diabetes finding the right treatment for the individual patients is becoming a key factor in care.

Paul Hudson, President of AstraZeneca US discussed some of the work the company is doing during the American Diabetes Association's 75th Annual Scientific Sessions in Boston. Hudson said much of the excitement centers around Forxiga which can be used in combination therapy.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.